1. Home
  2. FRLA vs PTHL Comparison

FRLA vs PTHL Comparison

Compare FRLA & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRLA
  • PTHL
  • Stock Information
  • Founded
  • FRLA 2021
  • PTHL 1998
  • Country
  • FRLA United States
  • PTHL China
  • Employees
  • FRLA N/A
  • PTHL N/A
  • Industry
  • FRLA
  • PTHL
  • Sector
  • FRLA
  • PTHL
  • Exchange
  • FRLA NYSE
  • PTHL Nasdaq
  • Market Cap
  • FRLA 71.4M
  • PTHL 72.9M
  • IPO Year
  • FRLA 2021
  • PTHL 2024
  • Fundamental
  • Price
  • FRLA $11.38
  • PTHL $4.54
  • Analyst Decision
  • FRLA
  • PTHL
  • Analyst Count
  • FRLA 0
  • PTHL 0
  • Target Price
  • FRLA N/A
  • PTHL N/A
  • AVG Volume (30 Days)
  • FRLA 7.3K
  • PTHL 295.9K
  • Earning Date
  • FRLA 01-01-0001
  • PTHL 11-11-2024
  • Dividend Yield
  • FRLA N/A
  • PTHL N/A
  • EPS Growth
  • FRLA N/A
  • PTHL N/A
  • EPS
  • FRLA N/A
  • PTHL N/A
  • Revenue
  • FRLA N/A
  • PTHL $572,291.00
  • Revenue This Year
  • FRLA N/A
  • PTHL N/A
  • Revenue Next Year
  • FRLA N/A
  • PTHL N/A
  • P/E Ratio
  • FRLA N/A
  • PTHL N/A
  • Revenue Growth
  • FRLA N/A
  • PTHL 2.32
  • 52 Week Low
  • FRLA $10.94
  • PTHL $3.32
  • 52 Week High
  • FRLA $11.87
  • PTHL $6.45
  • Technical
  • Relative Strength Index (RSI)
  • FRLA 52.55
  • PTHL N/A
  • Support Level
  • FRLA $11.36
  • PTHL N/A
  • Resistance Level
  • FRLA $11.42
  • PTHL N/A
  • Average True Range (ATR)
  • FRLA 0.02
  • PTHL 0.00
  • MACD
  • FRLA -0.00
  • PTHL 0.00
  • Stochastic Oscillator
  • FRLA 33.33
  • PTHL 0.00

About FRLA FORTUNE RISE ACQUISITION CORP

Fortune Rise Acquisition Corp is a blank check company.

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Share on Social Networks: